Saturday , 20 October 2018


Tag Archives: manic depression

Transition Therapeutics Inc: On Course to Alleviate Effects of Alzheimer's Disease, Bipolar Disorder & Type 2 Diabetes?

Transition Therapeutics Inc. (TSX:TTH/NASDAQ:TTHI) is in the process of developing an oral drug that has the potential to address both neuropsychiatric changes and cognitive declines associated with Alzheimer's Disease (AD) and stabilize the mood swings of those suffering from Bipolar Disorder (BPD) as well as a drug that plays a role in regulating obesity in those genetically predisposed to Type 2 Diabetes (DM11). With millions of people suffering from such health issues, and costing society billions of dollars in the treatment of same, such new drugs would be most welcome on all fronts. We wish Transition Therapeutics success in their endeavours and hope the development of each of their products come to fruition in rapid fashion. Here is their story to help you decide if its stock should be in your portfolio. Words: 1050

Read More »